Page last updated: 2024-10-29

ketanserin and Carcinoid Heart Disease

ketanserin has been researched along with Carcinoid Heart Disease in 2 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Carcinoid Heart Disease: Cardiac manifestation of gastrointestinal CARCINOID TUMOR that metastasizes to the liver. Substances secreted by the tumor cells, including SEROTONIN, promote fibrous plaque formation in ENDOCARDIUM and its underlying layers. These deposits cause distortion of the TRICUSPID VALVE and the PULMONARY VALVE eventually leading to STENOSIS and valve regurgitation.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rajamannan, NM1
Caplice, N1
Anthikad, F1
Sebo, TJ1
Orszulak, TA1
Edwards, WD1
Tajik, J1
Schwartz, RS1
Robertson, JI1
Stott, DJ1
Ball, SG1

Reviews

1 review available for ketanserin and Carcinoid Heart Disease

ArticleYear
Antihypertensive mode of action of ketanserin.
    Journal of cardiovascular pharmacology, 1987, Volume: 10 Suppl 3

    Topics: Adrenergic alpha-Antagonists; Aldosterone; Animals; Antihypertensive Agents; Blood Pressure; Carcino

1987

Other Studies

1 other study available for ketanserin and Carcinoid Heart Disease

ArticleYear
Cell proliferation in carcinoid valve disease: a mechanism for serotonin effects.
    The Journal of heart valve disease, 2001, Volume: 10, Issue:6

    Topics: Animals; Carcinoid Heart Disease; Cell Physiological Phenomena; Dose-Response Relationship, Drug; En

2001